Vanguard Group’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$697K Buy
127,031
+2,078
+2% +$10.7K ﹤0.01% 3865
2025
Q3
$499K Buy
124,953
+11,210
+10% +$47.1K ﹤0.01% 3946
2025
Q2
$308K Sell
113,743
-7,748
-6% -$20.5K ﹤0.01% 4019
2025
Q1
$637K Buy
121,491
+5,801
+5% +$36.7K ﹤0.01% 3827
2024
Q4
$889K Hold
115,690
﹤0.01% 3801
2024
Q3
$1.08M Buy
115,690
+8,453
+8% +$81.4K ﹤0.01% 3749
2024
Q2
$1.15M Sell
107,237
-27,359
-20% -$371K ﹤0.01% 3745
2024
Q1
$1.99M Buy
134,596
+1,600
+1% +$22.3K ﹤0.01% 3598
2023
Q4
$2.54M Buy
132,996
+1,767
+1% +$43.2K ﹤0.01% 3516
2023
Q3
$3.54M Buy
131,229
+1,464
+1% +$63.4K ﹤0.01% 3392
2023
Q2
$5.88M Buy
129,765
+5,387
+4% +$264K ﹤0.01% 3232
2023
Q1
$5.68M Buy
124,378
+3,290
+3% +$170K ﹤0.01% 3240
2022
Q4
$6.36M Buy
121,088
+21,258
+21% +$1.25M ﹤0.01% 3183
2022
Q3
$11.6M Buy
99,830
+12,766
+15% +$1.14M ﹤0.01% 2881
2022
Q2
$5.26M Sell
87,064
-1,692
-2% -$127K ﹤0.01% 3358
2022
Q1
$4.96M Buy
88,756
+48,771
+122% +$4.04M ﹤0.01% 3537
2021
Q4
$3.05M Sell
39,985
-8,851
-18% -$1.03M ﹤0.01% 3870
2021
Q3
$6.87M Buy
+48,836
New +$5.73M ﹤0.01% 3467

Other funds holding RLYB

Vanguard Group's RLYB Position: Q4 2025 in Review

Vanguard Group increased its Rallybio (RLYB) stake by 1.7% in Q4 2025, buying an estimated $10.7K and bringing the position to 127,031 shares worth $697K. The position accounts for ﹤0.01% of the portfolio, ranked #3865.

Vanguard Group first reported a position in RLYB in Q3 2021 and has held it in 18 quarters since. The position peaked at $11.6M in Q3 2022. 46 funds tracked by Wall St. Rank hold RLYB as of Q4 2025.

  • Vanguard Group held 127,031 shares of Rallybio worth $697K as of Q4 2025.
  • Vanguard Group bought 2,078 Rallybio shares in Q4 2025, an estimated $10.7K.
  • Rallybio made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3865 holding.
  • Vanguard Group first reported a position in Rallybio in Q3 2021 and has held it in 18 quarters since.
  • Vanguard Group's Rallybio position peaked at $11.6M in Q3 2022.
  • 46 funds tracked by Wall St. Rank held Rallybio as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.